Anthropic says its Claude agents found a new CRISPR-like enzyme system in phage DNA. A Copenhagen researcher says his team had already identified it, and he is asking what data the model saw.
A single infusion of the experimental CRISPR-Cas9 therapy CTX310 kept LDL cholesterol down 52.5% and triglycerides down 47.8% a year later in a first-in-human trial, with no serious treatment-related adverse events.
Using CRISPR gene editing, a team from Children's Hospital of Philadelphia (CHOP)and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth. This proof-of-concept study, published today in Science Translational Medicine,... Continue Reading →